Because of significant advances within the pharmaceutical business, new therapeutic ways are offered. However, The shortage of knowledge of the molecular mechanisms governing the destiny of antibodies results in a challenge to be able to find a curative cure. The best therapeutic approach needs early prognosis and an ideal nonpharmacological https://www.directivepublications.org/journal-of-arthritis-and-rheumatology/